Our aim is to be a reliable supplier and CDMO services provider for pharmaceutical intermediates and APIs
SCL was incorporated on December 20, 1993, as a Private Limited Company. Initially, it manufactured intermediates. On July 1, 1997, the company became a Public Limited Company and adopted its current name. In 2004, SCL established a new API manufacturing facility. Today, it offers a wide range of APIs and advanced intermediates in various therapeutic segments such as NSAIDs, cardiology, anti-cholinergic, CNS, anti-filarials, and anthelmintics, among others, to its customers. We are based in Panchkula, near Chandigarh, with two manufacturing facilities in Derabassi, Mohali (Punjab), for intermediates and APIs. The marketing office is located in Delhi NCR. We have acquired 22 acres of land for expanding facilities near the current site.
- • We are engaged in manufacturing bulk drugs/APIs and advanced intermediates.
- • We also specialize in providing CDMO services to clients in regulated markets in Europe, the USA, and Japan.
- • United States Food and Drug Administration (USFDA)
- • European Union Good Manufacturing Practices (EU-GMP)
- • Therapeutic Goods Administration (TGA) Australia
- • Ministry of Food and Drug Safety (MFDS) Korea
- • Japanese Pharmaceutical and Medical Devices Agency (JPMDA)
SCL caters to both the Domestic as well as the International Market. It derived ~60% of the total revenue from the International market and the remaining ~40% from the Domestic market. SCL is engaged in manufacturing Bulk Drugs/Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. We provide CDMO Services to our clients in regulated markets of Europe, USA and Japan.
SCL has over the years expanded its presence across the globe with key export markets being Europe (France, Spain, Germany, Italy, Greece, Austria, Portugal, Slovenia, Netherlands, Denmark), the United States of America (USA), Turkey, Japan, Korea, Brazil, Russia & CIS countries, South & Central America, Middle East & Northern Africa (MENA) region & other Asian countries.
The Company is headquartered at Panchkula (Haryana) near Chandigarh and has 2 Manufacturing facilities (one each for intermediates & APIs) located at Derabassi, Mohali (Punjab). Marketing office for the company is based out of Delhi NCR. Company has acquired 22acres of land for adding facilities near the existing site.
The Manufacturing facilities of the Company comply with the United States Food and Drug Administration (USFDA), European Union Good Manufacturing Practices (EU-GMP), TGA Australia, MFDS Korea & Japanese Pharmaceutical and Medical Devices Agency (JPMDA).
Our Growth Story
Our Core Values
Respectful of Compliance
True Partners to Our Customers
Commitment to Quality
Transparent Working
Creating Cost-Effective Solutions
Focus on Results
Our Mission & Vision
Know more about SCL Vision & Mission
- Delivering Value to life to Health
- Efficacy and Purity of products to enhance quality of human life
Complete compliance to the international standards of Health & Environment
- Committed to cause of Planet & People
Harnessing India’s knowledge skills for alleviating human suffering.
To be an Internationally recognized supplier of APIs and Pharmaceutical Intermediates to the regulated Markets.
To offer CMO Services for the regulated markets.
- Delivering Value to life to Health
- Efficacy and Purity of products to enhance quality of human life
- Complete compliance to the international standards of Health & Environment
- Committed to cause of Planet & People
- Harnessing India’s knowledge skills for alleviating human suffering.
- To be an Internationally recognized supplier of APIs and Pharmaceutical Intermediates to the regulated Markets.
- To offer CMO Services for the regulated markets.
